Publications by authors named "Victoria A Jenkins"

Claim this Profile
C
Chikungunya virus virus-like particle vaccine safety and immunogenicity in adults older than 65 years: a phase 3, randomised, double-blind, placebo-controlled trial.
Lauren C Tindale, Jason S Richardson, Deborah M Anderson, Jason Mendy, Sufia Muhammad, Victoria A Jenkins

Lancet· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chikungunya virus virus-like particle vaccine safety and immunogenicity in adolescents and adults in the USA: a phase 3, randomised, double-blind, placebo-controlled trial.
Jason S Richardson, Deborah M Anderson, Jason Mendy, Lauren C Tindale, Sufia Muhammad, Victoria A Jenkins

Lancet· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced Respiratory Syncytial Virus Load, Symptoms, and Infections: A Human Challenge Trial of MVA-BN-RSV Vaccine.
Elke Jordan, Golam Kabir, Stephanie Schultz, Günter Silbernagl, Darja Schmidt, Victoria A Jenkins

J Infect Dis· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Quest for a Respiratory Syncytial Virus Vaccine for Older Adults: Thinking beyond the F Protein.
Victoria A Jenkins, Bernard Hoet, Hubertus Hochrein, Laurence De Moerlooze

Vaccines (Basel)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The epidemiology of infectious diseases in Europe in 2020 versus 2017-2019 and the rise of tick-borne encephalitis (1995-2020).
Victoria A Jenkins, Guenter Silbernagl, Lorraine R Baer, Bernard Hoet

Ticks Tick Borne Dis· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Considering the market share of vaccines against tick-borne encephalitis reported in Austria.
Victoria A Jenkins, Bernard Hoet

J Travel Med· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perceptions of vaccine preventable diseases in Australian healthcare: focus on pertussis.
Julianne Bayliss, Roshnee Randhawa, Kyu-Bin Oh, Walid Kandeil, Victoria A Jenkins

Hum Vaccin Immunother· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pertussis in high-risk groups: an overview of the past quarter-century.
Victoria A Jenkins, Miloje Savic, Walid Kandeil

Hum Vaccin Immunother· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A systematic review of the burden of pertussis disease in infants and the effectiveness of maternal immunization against pertussis.
Walid Kandeil, Caroline van den Ende, Eveline M Bunge, Victoria A Jenkins, Maria Angeles Ceregido

Expert Rev Vaccines· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic-Pharmacodynamic modelling of intracellular Mycobacterium tuberculosis growth and kill rates is predictive of clinical treatment duration.
Ghaith Aljayyoussi, Victoria A Jenkins, Raman Sharma, Alison Ardrey, Samantha Donnellan

Sci Rep· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deciphering the metabolic response of Mycobacterium tuberculosis to nitrogen stress.
Kerstin J Williams, Victoria A Jenkins, Geraint R Barton, William A Bryant, Nitya Krishnan

Mol Microbiol· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deciphering the response of Mycobacterium smegmatis to nitrogen stress using bipartite active modules.
Kerstin J Williams, William A Bryant, Victoria A Jenkins, Geraint R Barton, Adam A Witney

BMC Genomics· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome wide analysis of the complete GlnR nitrogen-response regulon in Mycobacterium smegmatis.
Victoria A Jenkins, Geraint R Barton, Brian D Robertson, Kerstin J Williams

BMC Genomics· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adenylylation of mycobacterial Glnk (PII) protein is induced by nitrogen limitation.
Kerstin J Williams, Mark H Bennett, Geraint R Barton, Victoria A Jenkins, Brian D Robertson

Tuberculosis (Edinb)· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Free glucosylglycerate is a novel marker of nitrogen stress in Mycobacterium smegmatis.
Volker Behrends, Kerstin J Williams, Victoria A Jenkins, Brian D Robertson, Jacob G Bundy

J Proteome Res· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aspartate D48 is essential for the GlnR-mediated transcriptional response to nitrogen limitation in Mycobacterium smegmatis.
Victoria A Jenkins, Brian D Robertson, Kerstin J Williams

FEMS Microbiol Lett· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis